Investing in people
Lux Capital invests in emerging science and technology ventures at the outermost edges of what is possible.
We partner with iconoclastic inventors challenging the status quo and the laws of nature to bring their futuristic ideas to life.
Play Video Discover LUX"Securities" by Lux Capital
Ideas on science, technology, finance and the human condition
Subscribe to our weekly newsletter-
August 13, 2022
“Securities” by Lux Capital: (Week of Aug 8, 2022)
-
August 7, 2022
Finding wisdom within scientific fraud
-
August 6, 2022
“Securities” by Lux Capital: (Week of Aug 1, 2022)
-
August 3, 2022
“Securities” Podcast: VC 101: the denominator effect
-
August 1, 2022
“Securities” Podcast: How new communities are propelling the future of tech + bio
-
July 30, 2022
“Securities” by Lux Capital: (Week of July 25, 2022)
Our Companies
Want to know what the future will look like? Spend some time with our companies. You might meet a genetic engineer programming matter at the molecular level; a biologist and electrical engineer designing a new surgical robot; an astrophysicist launching rockets into space; or a materials scientist making circuits using a technique lifted from once-classified government programs.
-
Auris HealthAuris Health is an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.
-
CTRL-labs
CTRL-labs is changing the way we interact with computers. CTRL-labs was acquired by Facebook in 2019.
-
Desktop Metal
Desktop Metal enables high-speed, high-performance, 3D metal printing at production scale. The company listed publicly [NYSE: DM] in 2020.
-
Eikon Therapeutics
Eikon Therapeutics is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.
-
Hugging Face
Hugging Face is on a mission to advance and democratize Natural Language Processing.
-
Matterport
Matterport is the world’s most powerful all-in-one 3D data platform lets you turn a space into an accurate and immersive digital twin. The company listed publicly [NASDAQ: MTTR] in 2021.
-
Recursion Pharmaceuticals
Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
-
Saildrone
Saildrone collects valuable ocean data using a fleet of unmanned, autonomous sailing drones.
Our team is willing to take a chance on something other investors do not see.
We are neuroscientists, chemists, data scientists, computational biologists, economists, electrical engineers, machine-learning hackers and philosophers. We get fired up when audacious experimentation leads to heresy and reinvention.
